UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003949
Receipt number R000004739
Scientific Title A phase II study of Bevacizumab combined with Carboplatin and Weekly Paclitaxel for Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer. North Japan Lung Cancer Study Group Trial 1002
Date of disclosure of the study information 2010/07/31
Last modified on 2011/03/31 13:04:47

No. Disposal Last modified on Item of update
1 Insert 2010/07/26 18:15:10
2 Update 2010/08/02 15:42:06 Recruitment status
3 Update 2010/08/12 11:41:23 Public title
4 Update 2010/08/12 11:42:03 Narrative objectives1
5 Update 2010/08/12 11:44:16 Interventions/Control_1
6 Update 2010/08/13 12:51:24 Public title
7 Update 2010/08/13 12:52:27 Org. issuing International ID_1
8 Update 2011/01/27 20:16:16 Key inclusion criteria
Key inclusion criteria
9 Update 2011/01/28 20:35:53 Key inclusion criteria
10 Update 2011/03/17 14:22:40 Recruitment status
11 Update 2011/03/31 13:04:47 Email
Email1